MarketResearchNest.com presents “Global Osteosarcoma Market Size, Status and Forecast 2019-2025” new Research to its studies database.
An osteosarcoma (OS) is a cancerous tumor in a bone. Specifically, it is an aggressive malignant neoplasm that arises from primitive transformed cells of mesenchymal origin (and thus a sarcoma) and that exhibits osteoblastic differentiation and produces malignant osteoid. Osteosarcoma is the most common histological form of primary bone cancer. It is most prevalent in teenagers and young adults.
Osteosarcoma is the eighth-most common form of childhood cancer, comprising 2.4% of all malignancies in pediatric patients, and about 20% of all primary bone cancers. Incidence rates for osteosarcoma in U.S. patients under 20 years of age are estimated at 5.0 per million per year in the general population, with a slight variation between individuals of black, Hispanic, and white ethnicities (6.8, 6.5, and 4.6 per million per year, respectively). It is slightly more common in males (5.4 per million per year) than in females (4.0 per million per year).
In 2018, the global Osteosarcoma market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
Request a sample copy at
This report focuses on the global Osteosarcoma status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Osteosarcoma development in United States, Europe and China.
The key players covered in this study
- Spectrum Pharmaceuticals
- Hikma Pharmaceuticals
- Bellicum Pharmaceuticals
Market segment by Type, the product can be split into
- Intramedullary Osteosarcoma
- Juxtacortical Osteosarcoma
- Extra-Skeletal Osteosarcoma
Market segment by Application, split into
- Hospital and Clinics
- Cancer Research Institutes
Market segment by Regions/Countries, this report covers
- United States
- Southeast Asia
- Central and South America
Browse full table of contents and data tables at
The study objectives of this report are:
- To analyze global Osteosarcoma status, future forecast, growth opportunity, key market and key players.
- To present the Osteosarcoma development in United States, Europe and China.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Osteosarcoma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Order a Purchase Report Copy at
About us: – MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on World industries, organizations, products, and trends.
Contact us: –
Mr. Jeet Jain
+91-888-841-3131(IND) | +1-240-284-8070(U.S) | +44-20-3290-4151(U.K)